Regulation of tight junction assembly and epithelial morphogenesis by the heat shock protein Apg-2
© Aijaz et al; licensee BioMed Central Ltd. 2007
Received: 23 May 2007
Accepted: 20 November 2007
Published: 20 November 2007
Tight junctions are required for epithelial barrier formation and participate in the regulation of signalling mechanisms that control proliferation and differentiation. ZO-1 is a tight junction-associated adaptor protein that regulates gene expression, junction assembly and epithelial morphogenesis. We have previously demonstrated that the heat shock protein Apg-2 binds ZO-1 and thereby regulates its role in cell proliferation. Here, we addressed the question whether Apg-2 is also important for junction formation and epithelial morphogenesis.
We demonstrate that depletion of Apg-2 by RNAi in MDCK cells did not prevent formation of functional tight junctions. Similar to ZO-1, however, reduced expression of Apg-2 retarded de novo junction assembly if analysed in a Ca-switch model. Formation of functional junctions, as monitored by measuring transepithelial electrical resistance, and recruitment of tight and adherens junction markers were retarded. If cultured in three dimensional extracellular matrix gels, Apg-2 depleted cells, as previously shown for ZO-1 depleted cells, did not form hollow polarised cysts but poorly organised, irregular structures.
Our data indicate that Apg-2 regulates junction assembly and is required for normal epithelial morphogenesis in a three-dimensional culture system, suggesting that Apg-2 is an important regulator of epithelial differentiation. As the observed phenotypes are similar to those previously described for ZO-1 depleted cells and depletion of Apg-2 retards junctional recruitment of ZO-1, regulation of ZO-1 is likely to be an important functional role for Apg-2 during epithelial differentiation.
Epithelial tight junctions are the most apical component of the junctional complex and are critical for epithelial barrier function as they form the paracellular diffusion barrier [1–3]. Tight junctions are composed of several transmembrane proteins that are linked to a cytoplasmic plaque and the actin cytoskeleton [4, 5]. This cytoplasmic plaque consists of a protein network formed by adaptor proteins with multiple protein/protein interaction motifs, cytoskeletal linkers and signalling proteins such as protein kinases and phosphatases [6, 7]. These junction associated protein complexes also interact with dual localisation proteins that localise to both the junction and the nucleus . Several of these junctional components have been linked to the regulation of epithelial proliferation, differentiation and polarisation [9, 10].
ZO-1 is the first tight junction protein identified and functions as a junctional adaptor that interacts with multiple transmembrane proteins, components of the junctional plaque and actin filaments [4, 5, 11, 12]. ZO-1 is expressed by most cells and, in the absence of tight junctions, can associate with other cell-cell adhesion complexes, such as adherens and gap junctions [13–15]. Repression of ZO-1 expression in different epithelial cell lines revealed that ZO-1 is not required for junction formation and polarisation in two-dimensional (2-D) culture systems [16, 17]. In three-dimensional cultures (3-D), however, normal ZO-1 expression is required for the formation of polarised hollow cysts, indicating that it plays a role in the regulation of epithelial morphogenesis .
ZO-1 has been directly associated with a signalling function of tight junctions. ZO-1 binds with its SH3 domain to the Y-box transcription factor ZONAB (DbpA), which results in cytoplasmic sequestration and inhibition of the transcriptional activity of the latter protein . The ZO-1/ZONAB pathway regulates epithelial proliferation and expression of genes important for epithelial differentiation and cell cycle progression such as erbB-2, cyclin D1 and PCNA [18–20]. The SH3 domain of ZO-1 also interacts with the heat shock protein Apg-2 . Apg-2 and ZONAB compete for binding to ZO-1, resulting in ZONAB dissociation and activation if the interaction with Apg-2 is favoured by conditions such as, for example, heat shock. Expression of all three proteins can be deregulated in different epithelial cancers, suggesting that they might be functionally relevant for the maintenance of the epithelial cell type and tumorigenesis [22–30].
Given the modulatory role of ZO-1 during junction formation, its involvement in large protein complexes, and the role of heat shock proteins as folding and assembly factors, we tested whether Apg-2 regulates junction formation. Our data indicate that Apg-2 is not essential for the formation of functional tight junctions but regulates junction assembly in 2-D cultures similar to its interaction partner ZO-1. In 3-D cultures, however, Apg-2 was required for normal epithelial morphogenesis, suggesting that the heat shock protein regulates pathways important for epithelial polarisation and differentiation.
Apg-2 regulates the assembly of functional tight junctions
Apg-2 binds to the SH3 domain of ZO-1, and this domain is important for the regulation of junction assembly in MDCK cells [16, 21]. To test whether Apg-2 is also required for junction formation, we made use of previously described MDCK cell lines permitting the conditional depletion of either Apg-2 or ZO-1 [18, 21]. In these cell lines, RNA interference is induced by the addition of tetracycline, which inactivates a co-transfected repressor, resulting in expression of shRNAs. We made use of four different cell lines: two expressing two different shRNA constructs that target different sequences of Apg-2 (z2 and z5; ), one for the repression of ZO-1 , and a control cell line expressing a non-targeting construct.
Figure 2B shows that depletion of ZO-1 resulted in the previously described retardation of junction formation [16, 17]. TER developed more slowly and only reached 50% of the value of control cultures after 12 hours. After 24 hours, however, the values of depleted and non-depleted cultures were the same. If Apg-2 was depleted, TER development was also retarded and cultures reached about 60% of the value of control cultures after 12 hours (Fig. 2C and 2D). As in cells with reduced ZO-1 expression, the TER values measured in depleted and non-depleted cultures were the same after 24 hours. Similarly, all cell lines reached steady state values of about 60 Ωcm2 after 2 days. Thus, normal expression of Apg-2, like ZO-1, is not required for the formation of electrically resistant tight junctions, but the heat shock protein regulates the kinetics of junction formation. Normal expression levels of Apg-2 seem to be sufficient to support efficient junction assembly, as overexpression did not affect the development of TER in a calcium switch (not shown).
Tight junctions restrict paracellular permeability of ions as well as of hydrophilic molecules based on their size. As the two parameters are not always regulated in the same way, we measured paracellular permeability of fluorescent dextrans in steady state cultures. Cultures were incubated for 3 hours with 4 kD or 70 kD fluorescent dextran and diffusion in the apical-to-basolateral direction was then determined by measuring fluorescence in the basolateral medium. Figure 2E shows that neither depletion of ZO-1 nor Apg-2 affected paracellular permeability of 4 kD dextran. We could also not detect an effect on 70 kD dextran diffusion (not shown). Thus, Apg-2- and ZO-1-depleted cells assembled junctions that represented functional paracellular diffusion barriers.
Depletion of Apg-2 retards the recruitment of ZO-1 and interacting proteins
ZO-1 depletion has also been associated with a retardation in the maturation of adherens junctions from spot-like to belt-like junctions . Hence, we tested whether Apg-2-depletion influenced the junctional recruitment of the adherens junction markers α-catenin, which is known to interact with ZO-1 [37, 38], and E-cadherin. Indeed, α-catenin was recruited more slowly and E-cadherin required more time to form belt-like junctions (Fig. 4B, 5E and 5F). Thus, Apg-2 depletion retards tight junction formation as well as maturation of adherens junctions.
At later time points, the junctional distribution of tight and adherens junction markers was the same in Apg-2 depleted and non depleted cells. We could also not detect any differences in the Triton X-100 insolubility of different junctional proteins (not shown). Together with the functional data in figure 2, this suggests that Apg-2 is not required for junction formation but functions as a regulator.
Apg-2 is required for epithelial morphogenesis in 3-D cultures
Apg-2 regulates signalling by ZO-1 and ZONAB, and both proteins have been associated with the regulation of epithelial morphogenesis of MDCK cells cultured in extracellular matrix gels [18, 21]. Hence, we next tested whether Apg-2 depletion affected the capability of MDCK cells to form polarised hollow cysts in 3-D cultures.
Tight junctions are composed of multimeric protein complexes often formed by different types of proteins that interact with each other. Epithelial junction formation is a sequential process that starts with the formation of a primordial adhesive junction that then matures into distinct tight and adherens junctions. ZO-1 can interact with different components of tight and adherens junctions and appears to play a modulatory role during formation of both types of junctions [16, 17, 36]. ZO-1 also regulates gene expression, cell proliferation and epithelial morphogenesis [18–20]. ZO-1's role in gene expression is regulated by an interaction with the heat shock protein Apg-2 . Here we show that Apg-2 also modulates junction formation and is required for normal epithelial morphogenesis in 3-D cultures.
Depletion of Apg-2 affects junction formation in a similar way as depletion of ZO-1: formation of functional junctions was retarded, but not prevented, and the inhibition was only modest. In the case of ZO-1, it seems that its function in tight junction formation is at least in part redundant as depletion of ZO-2 in ZO-1 knockout cells prevents tight junction formation . Whether MDCK cells express other proteins with a similar function as Apg-2 is currently not known; however, it is conceivable that other heat shock proteins might also aid junction formation. Alternatively, it could be that Apg-2 functions as a catalyst; hence, its function is not required, but its presence accelerates junction formation.
The mechanism by which Apg-2 regulates junction assembly is not known. It could be that Apg-2 regulates formation of ZO-1 complexes. We have thus far not been able, however, to detect differences in proteins co-precipitating with ZO-1 if Apg-2 was depleted (KM and MSB, unpublished). Nevertheless, it is possible that this involves interactions that are not detergent resistant or other unknown proteins. We could also not detect clear differences in the Triton X-100 insolubility of junctional proteins between control and Apg-2 depleted cells, but there was only a small pool of insoluble proteins at early time points when junction formation was inhibited (not shown). As we have only observed kinetic differences in junction formation, minor quantitative changes in complex formation might be involved that would be difficult to assess experimentally.
The SH3 domain of ZO-1, which is the domain that interacts with Apg-2, is not only required but also sufficient to rescue junction formation in ZO-1 depleted MDCK cells [16, 21]. However, the SH3 domain by itself remains in the cytosol and is not recruited to cell junctions [18, 19], suggesting that it binds to a cellular factor that does not need to be recruited to junctions. One such factor is the transcription factor ZONAB; however, neither overexpression nor depletion of ZONAB affects tight junction formation (KM and MSB, unpublished) . Hence, one possibility is that ZO-1 regulates a function of Apg-2 rather than the other way around. In fact, ZO-1 does not bind the peptide-binding domain of Apg-2 but to the N-terminal domain containing the ATPase. Hence, ZO-1 binding might affect yet to be discovered functional properties of Apg-2 such as, for example, release of another protein bound to the peptide-binding domain. It will therefore be important to analyse how ZO-1 binding affects the biochemical properties of Apg-2 and to search for Apg-2 substrates and other interacting proteins.
Apg-2 also regulates epithelial morphogenesis in 3-D cultures. Apg-2 depleted cells did not form hollow cysts but poorly organised structures with none or several small lumen. The disorganised nature of these structures was evident from different immunofluorescence labellings that showed that their cells did not possess a uniform polarity or, in the absence of a clear lumen, maintained apical markers at the outer surface of the cysts. Strikingly, we observed the same phenotype in cells depleted of ZO-1. As overexpression of ZONAB also caused a similar phenotype, we considered it as likely that the reduced expression of ZO-1 affected morphogenesis by stimulating ZONAB . Apg-2 depletion, however, does not stimulate ZONAB but inhibits it, as the two proteins compete with each other for binding to the SH3 domain of ZO-1 . However, it is possible that deregulation, and not just activation, of the ZO-1/ZONAB pathway causes defects in the development of polarised hollow cysts. Alternatively, ZO-1 might regulate a function of Apg-2 that is important for morphogenesis. Moreover, Apg-2 is expressed in different subcellular locations and, like other heat shock proteins, might bind many different proteins and, hence, regulate different types of processes. Nevertheless, the similarity of the phenotypes in junction formation and 3-D morphogenesis caused by depletion of Apg-2 and ZO-1 suggests that the two interacting proteins function in at least overlapping pathways during epithelial differentiation.
Depletion of Apg-2 in MDCK cells retards junction assembly and inhibits epithelial morphogenesis in three-dimensional cultures, indicating that Apg-2 is a functionally relevant regulator of epithelial differentiation.
Cell lines and culture conditions
Stable MDCK cell lines for conditional, tetracycline-induced RNAi of Apg-2 and ZO-1, as well as control lines were previously described [18, 21]. For Apg-2, cell lines expressing shRNAs targeting two different sequences were used. For 3-D morphogenesis assays, the cells were plated in a matrigel/collagen mix and cultured for 7 days as detailed elsewhere . For calcium switch assays, the cells were trypsinised for 20 minutes, resuspended in normal DMEM with 10% fetal calf serum, and incubated at room temperature for 15 minutes. The cells were then pelleted by centrifugation, resuspended in low calcium medium (spinner culture medium, Sigma) with 10% dialysed fetal calf serum, 2 mM L-glutamine and 1 mM sodium pyruvate). The cells were centrifuged again and resuspended in low calcium medium at a concentration of 1.5 × 106 cells/ml. 0.5 ml of this suspension was then plated per tissue culture insert (12-well clusters, 0.4 μm pore size, Corning). 1.5 ml of low calcium medium was added to the outer chambers. After 18 hours, the low calcium medium was replaced by standard tissue culture medium (DMEM with 10% fetal calf serum) and TER measurements were started after an initial incubation of 30 minutes at 37°C. For induction of RNAi, tetracycline was added to the low calcium medium at time of plating.
Functional analysis of tight junctions
TER was measured at 37°C with an EVOM (World Precision Instruments) using an AC square wave current (+/- 20 mA, 12.5 Hz) and stick electrodes . TER values for individual cultures were calculated by subtracting the values measured for filters without cells. For paracellular diffusion measurements, 4 kD FITC-dextran and 70 kD-Rhodamine B dextran (Sigma) were dissolved in medium and added to the apical chambers (1 mg/ml each) and diffusion to the basolateral side of the two dextrans was then assayed simultaneously as described . Fluorescence was determined with a FLUOstar Optima (BMG LABTECH) plate reader (FITC-Dextran: Exc: 485 nm and Em: 544 nm and/or Rhodamine B-Dextran: Exc: 520 nm and Em: 590 nm).
At the end of calcium switch experiments and permeability studies, filters were excised from their holders and transferred into tubes containing 300 μl of SDS-PAGE sample buffer. After separation on 5–15% gradient gels and transfer to nitrocellulose, expression of specific proteins was analysed by immunoblotting using the ECL detection kit (Amersham) . Rabbit polyclonal antibodies specific for Apg-2, ZO-1, ZO-2, ZO-3 and mouse monoclonal antibody against α-tubulin were previously described [21, 40, 42, 43].
Cells were fixed with either methanol, or paraformaldehyde and then permeabilised with 0.3% Triton X-100 as described [18, 19, 41]. Incubations with primary antibodies, and FITC- and Cy3-conjugated secondary antibodies (Jackson Immunochemicals, Inc.) as well as mounting of samples were performed as previously described for 2-D cultures  and 3-D cultures , respectively. Antibodies against Apg-2, ZO-1, ZO-2, ZO-3, GEF-H1 and E-cadherin were previously described [21, 40, 42, 44]. The Golgi marker GP73 was labelled with an affinity purified rabbit polyclonal antibody raised against a recombinant protein containing the entire luminal domain. The antibodies against the following antigens were obtained from commercial sources: occludin, claudin-4, and cingulin, Zymed, Inc.; α-catenin, Sigma; β-catenin and erbB-2, Santa Cruz Biotechnology, Inc. The mouse anti-GP135/podocalyxin antibody was kindly provided by Dr. G. Ojakian (SUNY Downstate Medical Center, Brooklyn, New York, USA) . Phase contrast and epifluorescence images were obtained with a Leica DM1 RB microscope equipped with a 63×/1.4 oil immersion objective and a Hamamatsu ORCA285 camera. Confocal images were acquired with eiher a Leica LCS SP2 or a BioRadiance2000 microscope also using a 63× oil immersion objectives. The image acquisition software supplied by the manufacturers was used to collect the images. Image brightness and contrast were adjusted with Adobe Photoshop.
We are grateful to Dr. G. Ojakian for providing anti-GP135/podocalyxin antibody. This research was supported by the BBSRC (BB/C514458/1).
- Anderson JM, Van Itallie CM, Fanning AS: Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol. 2004, 16: 140-145. 10.1016/j.ceb.2004.01.005.View ArticlePubMed
- Schneeberger EE, Lynch RD: The tight junction: a multifunctional complex. Am J Physiol. 2004, 286: C1213-28. 10.1152/ajpcell.00558.2003.View Article
- Cereijido M, Contreras RG, Shoshani L: Cell adhesion, polarity, and epithelia in the dawn of metazoans. Physiol Rev. 2004, 84: 1229-1262. 10.1152/physrev.00001.2004.View ArticlePubMed
- Tsukita S, Furuse M, Itoh M: Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001, 2: 286-293. 10.1038/35067088.View Article
- Aijaz S, Balda MS, Matter K: Tight Junctions: Molecular Architecture and Function. Int Rev Cytol. 2006, 248: 261-298.View ArticlePubMed
- Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE: Tight junction proteins. Prog Biophys Mol Biol. 2003, 81: 1-44. 10.1016/S0079-6107(02)00037-8.View ArticlePubMed
- Matter K, Balda MS: Signalling to and from tight junctions. Nat Rev Mol Cell Biol. 2003, 4: 225-236. 10.1038/nrm1055.View ArticlePubMed
- Matter K, Balda MS: Tight junctions, gene expression and nucleo-junctinal interplay. J Cell Sci. 2007, 120: 1505-1511. 10.1242/jcs.005975.View ArticlePubMed
- Matter K, Aijaz S, Tsapara A, Balda MS: Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol. 2005, 17: 453-458. 10.1016/j.ceb.2005.08.003.View ArticlePubMed
- Shin K, Fogg VC, Margolis B: Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 2006, 22: 207-235. 10.1146/annurev.cellbio.22.010305.104219.View ArticlePubMed
- Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA: Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986, 103: 755-766. 10.1083/jcb.103.3.755.View ArticlePubMed
- Fanning AS: Organization and the regulation of the tight junction by the actin-myosin cytoskeleton. Tight Junctions. Edited by: Anderson JM and Cereijido M. 2001, , CRC Press, 265-284. 2nd
- Itoh M, Nagafuchi A, Yonemura S, Kitani-Yasuda T, Tsukita S: The 220-kD protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelial cells: cDNA cloning and immunoelectron microscopy. J Cell Biol. 1993, 121: 491-502. 10.1083/jcb.121.3.491.View ArticlePubMed
- Giepmans BN, Moolenaar WH: The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol. 1998, 8: 931-934. 10.1016/S0960-9822(07)00375-2.View ArticlePubMed
- Toyofuku T, Yabuki M, Otsu K, Kuzuya T, Hori M, Tada M: Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J Biol Chem. 1998, 273: 12725-12731. 10.1074/jbc.273.21.12725.View ArticlePubMed
- McNeil E, Capaldo CT, Macara IG: Zonula occludens-1 function in the assembly of tight junctions in Madin-Darby canine kidney epithelial cells. Mol Biol Cell. 2006, 17: 1922-1932. 10.1091/mbc.E05-07-0650.PubMed CentralView ArticlePubMed
- Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, Tsukita S: Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J Biol Chem. 2004, 279: 44785-44794. 10.1074/jbc.M406563200.View ArticlePubMed
- Sourisseau T, Georgiadis A, Tsapara A, Ali RR, Pestell RG, Matter K, Balda MS: Regulation of PCNA and cyclin D1 expression and epithelial morphogenesis by the ZO-1 regulated transcription factor ZONAB/DbpA. Mol Cell Biol. 2006, 26: 2387-2398. 10.1128/MCB.26.6.2387-2398.2006.PubMed CentralView ArticlePubMed
- Balda MS, Matter K: The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J. 2000, 19: 2024-2033. 10.1093/emboj/19.9.2024.PubMed CentralView ArticlePubMed
- Balda MS, Garrett MD, Matter K: The ZO-1 associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density. J Cell Biol. 2003, 160: 423-432. 10.1083/jcb.200210020.PubMed CentralView ArticlePubMed
- Tsapara A, Matter K, Balda MS: The Heat Shock Protein Apg-2 Binds to the Tight Junction Protein ZO-1 and Regulates Transcriptional Activity of ZONAB. Mol Biol Cell. 2006, 17: 1322-1330. 10.1091/mbc.E05-06-0507.PubMed CentralView ArticlePubMed
- Hoover KB, Liao SY, Bryant PJ: Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol. 1998, 153: 1767-1773.PubMed CentralView ArticlePubMed
- Martin TA, Watkins G, Mansel RE, Jiang WG: Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer. 2004, 40: 2717-2725. 10.1016/j.ejca.2004.08.008.View ArticlePubMed
- Morita K, Tsukita S, Miyachi Y: Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br J Dermatol. 2004, 151: 328-334. 10.1111/j.1365-2133.2004.06029.x.View ArticlePubMed
- Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol. 2005, 18: 511-518. 10.1038/modpathol.3800301.View ArticlePubMed
- Kleeff J, Shi X, Bode HP, Hoover K, Shrikhande S, Bryant PJ, Korc M, Buchler MW, Friess H: Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer. Pancreas. 2001, 23: 259-265. 10.1097/00006676-200110000-00006.View ArticlePubMed
- Takai E, Tan X, Tamori Y, Hirota M, Egami H, Ogawa M: Correlation of translocation of tight junction protein Zonula occludens-1 and activation of epidermal growth factor receptor in the regulation of invasion of pancreatic cancer cells. Int J Oncol. 2005, 27: 645-651.PubMed
- Arakawa Y, Kajino K, Kano S, Tobita H, Hayashi J, Yasen M, Moriyama M, Hino O: Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. Biochem Biophys Res Commun. 2004, 322: 297-302. 10.1016/j.bbrc.2004.04.208.View ArticlePubMed
- Hayashi J, Kajino K, Umeda T, Takano S, Arakawa Y, Kudo M, Hino O: Somatic mutation and SNP in the promoter of dbpA and human hepatocarcinogenesis. Int J Oncol. 2002, 21: 847-850.PubMed
- Gotoh K, Nonoguchi K, Higashitsuji H, Kaneko Y, Sakurai T, Sumitomo Y, Itoh K, Subjeck JR, Fujita J: Apg-2 has a chaperone-like activity similar to Hsp110 and is overexpressed in hepatocellular carcinomas. FEBS Lett. 2004, 560: 19-24. 10.1016/S0014-5793(04)00034-1.View ArticlePubMed
- González-Mariscal L, Contreras RG, Bolivar JJ, Ponce A, Chávez de Ramirez B, Cereijido M: Role of calcium in tight junction formation between epithelial cells. Am J Physiol. 1990, 259: C978-C986.PubMed
- Cereijido M, Robbins ES, Dolan WJ, Rotunno CA, Sabatini DD: Polarized monolayers formed by epithelial cells on a permeable and translucent support. J Cell Biol. 1978, 77: 853-880. 10.1083/jcb.77.3.853.View ArticlePubMed
- Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S: Occludin: A novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993, 123: 1777-1788. 10.1083/jcb.123.6.1777.View ArticlePubMed
- Cordenonsi M, D'Atri F, Hammar E, Parry DA, Kendrick-Jones J, Shore D, Citi S: Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol. 1999, 147: 1569-1582. 10.1083/jcb.147.7.1569.PubMed CentralView ArticlePubMed
- Aijaz S, D'Atri F, Citi S, Balda MS, Matter K: Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell. 2005, 8: 777-786. 10.1016/j.devcel.2005.03.003.View ArticlePubMed
- Ikenouchi J, Umeda K, Tsukita S, Furuse M: Requirement of ZO-1 for the formation of belt-like adherens junctions during epithelial cell polarization. J Cell Biol. 2007, 176: 779-786. 10.1083/jcb.200612080.PubMed CentralView ArticlePubMed
- Rajasekaran AK, Hojo M, Huima T, Rodriguez-Boulan E: Catenins and zonula occludens-1 form a complex during early stages in the assembly of tight junctions. J Cell Biol. 1996, 132: 451-463. 10.1083/jcb.132.3.451.View ArticlePubMed
- Itoh M, Nagafuchi A, Moroi S, Tsukita S: Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol. 1997, 138: 181-192. 10.1083/jcb.138.1.181.PubMed CentralView ArticlePubMed
- Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, Matsui T, Tsukita S, Furuse M: ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell. 2006, 126: 741-754. 10.1016/j.cell.2006.06.043.View ArticlePubMed
- Matter K, Balda MS: Functional analysis of tight junctions. Methods. 2003, 30: 228-234. 10.1016/S1046-2023(03)00029-X.View ArticlePubMed
- Balda MS, Whitney JA, Flores C, González S, Cereijido M, Matter K: Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol. 1996, 134: 1031-1049. 10.1083/jcb.134.4.1031.View ArticlePubMed
- Benais-Pont G, Punn A, Flores-Maldonado C, Eckert J, Raposo G, Fleming TP, Cereijido M, Balda MS, Matter K: Identification of a tight junction-associated guanine nucleotide exchange factor that activates Rho and regulates paracellular permeability. J Cell Biol. 2003, 160: 729-740. 10.1083/jcb.200211047.PubMed CentralView ArticlePubMed
- Kreis TE: Microtubules containing detyrosinated tubulin are less dynamic. EMBO J. 1987, 6: 2597-2606.PubMed CentralPubMed
- Gumbiner B, Simons K: A functional assay for proteins involved in establishing an epithelial occluding barrier: Identification of a uvomorulin-like polypeptide. J Cell Biol. 1986, 102: 457-468. 10.1083/jcb.102.2.457.View ArticlePubMed
- Ojakian GK, Schwimmer R: The polarized distribution of an apical cell surface glycoprotein is maintained by interactions with the cytoskeleton of Madin-Darby canine kidney cells. J Cell Biol. 1988, 107: 2377-2387. 10.1083/jcb.107.6.2377.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.